The Value of Pharmacovigilance in Building Resilient Health Systems Post-COVID
No hay miniatura disponible
Fecha
Título de la revista
ISSN de la revista
Título del volumen
Editor
World Bank, Washington, DC
Resumen
Descripción
Although indispensable for improving
health outcomes, medicines and vaccines or their
administration and use can produce adverse effects,
requiring continuous vigilance to ensure that the benefits
outweigh the risks. Monitoring the safety of the use of
marketed medicines and vaccines, also known as
pharmacovigilance, should therefore become much more
explicit in efforts to strengthen health systems and prepare
for public health crises and normal times because the world
is determined to build back better after the COVID-19
pandemic. The objective of this report is to examine the
importance of pharmacovigilance in a health system both
during a health crisis and in normal times, describe the
function, structure, and processes of a functional
pharmacovigilance system, and explain the value of drug
safety monitoring in building resilience in health systems
post-COVID-19 pandemic.
Palabras clave
PUBLIC HEALTH RISK RESPONSE, HEALTH SYSTEMS, COVID-19 PANDEMIC RESPONSE, EMERGING DISEASE CHALLENGE, PUBLIC HEALTH SURVEILLANCE, SEASONAL EPIDEMIC INFECTION, NATIONAL HEALTH SURVEILLANCE SYSTEM, PHARMACOVIGILANCE, KOREA-WORLD BANK PARTNERSHIP FACILITY (KWPF), CHINA-WORLD BANK PARTNERSHIP TRUST FUND (CWPF)